Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) unit Shanghai Fosun Health Technology will inject 30 million yuan into Shanghai Zhuoerhui Integrated Outpatient.
The capital contribution will mainly be to support the target company's daily operations and the construction of its disciplines, branding, and marketing system.
Following completion, Fosun Health's shareholding in the target will rise to 67.1872% from 57.5363%, a Thursday filing with the Hong Kong bourse said.
Shanghai Zhuoerhui Integrated Outpatient mainly provides medical services such as physical examination and general and specialist outpatient clinics.